Unfortunately, one can observe that, from
approximately 20 traditional pharmaceutical companies investing in antibiotic
research in the 1980s, there are now only five with significant active
internal research programs. As a result, most novel antibiotic development is
now being conducted by small biotech companies.
Business data and Trends across the world. Mobile Phone (237) (679 78 45 18/ or 694 74 90 25)! E-mail: taatjene@gmail.com
Comments
Post a Comment